For information about ongoing clinical trials, please click here.

Summer 2014

Dear Friend,

As we come together to create an Allergy Center at Stanford, it is inspiring to work with our community to make transformative changes in the lives of our patients and families living with allergies.
Last month, an outpouring of community members ran or walked in support of the Center, placing first among the fundraising teams at the Lucile Packard Summer Scamper. Additional events are in the works for the coming months—we hope to see you there! The Center relies on its team of Community Council volunteers to help spread awareness, plan outreach events and fundraise for allergy research. Join our volunteer Council of allergy parents, advocates and others committed to actively supporting the Center by filling out this volunteer form with your interests
As always, we are deeply appreciative of your support as we work toward our vision of the Center: "Transforming the Lives of our Patients and Families Through Innovative Science and Compassionate Care."


Dr. Kari Nadeau
Center Director Dr. Kari Nadeau shares the vision, goals and research priorities for Stanford's Allergy Center in this interview.

The magnitude of Stanford’s contributions to allergy research is perhaps best expressed through the voices of the patients themselves. Find out how their lives have changed since participating in a food allergy trial at Stanford.

Stanford Allergy Research 

Recent Publications
  • Multiple allergen oral immunotherapy improves quality of life for caregivers of food-allergic patients. Read full study.
  • Stanford lab team finds beneficial role for how IgE might work in the immune system. Read study abstract.
  • Stanford develops new small molecule to more rapidly provide safe, efficient therapies for near-fatal allergies. Read study abstract
  • Vitamin D3 found to promote immunotherapy in mouse models of allergic disease. Read study abstract
  • Stanford publication reviews research on epigenetic regulation of asthma and allergic disease. Read full review
  • Stanford publication reviews the roles of regulatory T cells in allergy and asthma. Read review summary.
  • Stanford study identifies new method for understanding interactions of mechanical and biochemical cues on the signaling responses of immune cells. Read study abstract.
Current research
  • The Nadeau Lab is developing a method of treating allergies with cell therapy, focusing on near-fatal food allergies first. Stanford's Dr. Bacchetta and Dr. Roncorolo are pioneers in the use of specific cell therapy to help fight diseases. 
  • Stanford develops new diagnostic tool that identifies allergies with over 95% accuracy. This patented blood test will fill a much-needed gap in diagnostic measures for allergies once it becomes available to the public. 

Upcoming Events

Stanford Allergy Center Talk: October 27
Mark your calendars for a talk on food allergies led by members of Stanford's Allergy Center medical team. This free event will be held at the Lucile Packard Children's Hospital Auditorium at 7:00pm. Registration details to follow. 

Food Allergy Research and Education (FARE) Walk: October 11
Walk with Stanford's Allergy Center Team at FARE's annual walk. All proceeds will support FARE's mission to find a cure for food allergies and keep individuals with food allergies safe and included. Register here!

Please visit the community section of our website to stay abreast of upcoming Center events.

Get Involved!

Join our team of Stanford Allergy Center Community Council volunteers and make a difference in allergy awareness, advocacy and fundraising initiatives. Simply fill out this volunteer form with your interests

Follow us on Facebook for up-to-the-minute updates on allergy research developments at Stanford.
Support us in making Stanford's vision for an Allergy Center at Stanford a reality.

What's New

Packard Scamper Raises Funds for Stanford Allergy Center 
Community members in support of the Stanford Allergy Center raised over $54,000 at the Lucile Packard Annual Summer Scamper held on June 22. Thank you to all who participated!

Pictured: Fujii Matta Family.
See additional Scamper photos.

CA Stock Epinephrine Bill Gains Momentum 
With your support, California stock epinephrine bill SB 1266 passed the Assembly Education Committee and will head to the Assembly Appropriations Committee in August. If passed, this bill will increase the ability of California public and charter schools to maintain a supply of stock epinephrine and administer it to any student having an anaphylactic reaction. Stay tuned for actions you can take to support this important bill.

Pictured: Dr. Travis Miller (Physician for the Allergy Station), Dr. Kari Nadeau, Cathy Owens (School Nurse), Members of Stanford Allergy Center Community Council and California Advocates for Food Allergies (CAFA), other advocates at SB 1266 senate hearing.

Center Fundraising Efforts Continue, Over $12M Raised To Date 
Thanks to our generous donors, over $12M has been raised toward the establishment of Stanford's Allergy Center. With your support, Stanford will continue to prioritize patient safety while remaining on the cutting edge of allergy research. Please join us in raising the remaining funds needed to make the Center a reality, and look out for additional opportunities to support the Center this September. 

In the News

NBC News 
Food Allergy Treatment for Children Show Promise 

Contemporary Pediatrics
Immunotherapy for Food Allergy: Promise and Progress 

Liberty Voice
New Treatments for Severe Food Allergies May Save Children's Lives

More In the News items

Clinical Trials

Stanford Allergy Center is currently enrolling for three oral immunotherapy (OIT) food allergy clinical trials. If you are interested in being screened for any of these studies, please send us an email.

Upon completion of your participating trial, you will be offered state of the art immunotherapy treatment for all your other allergies as part of your continuing care at our Allergy Center. 

Peanut OIT Study: Safety, Efficacy, and Discovery (POISED study): Enrolling 120 peanut-allergic patients ages 8-55 years old. Find out specific details on the trial, including inclusion and exclusion criteria here.
OIT for Wheat Allergy (Wheat OIT study): Stanford site is enrolling 12 patients ages 4-30 years old with a diagnosed wheat allergy.  Specific details on the trial, including inclusion and exclusion criteria, can be found here.
Peanut OIT in Children (IMPACT study): Stanford site is enrolling 29 peanut-allergic children ages 12 to 48 months. For specific details on the trial, including inclusion and exclusion criteria, please click here

Stanford Allergy Center News is produced in collaboration with the Stanford Allergy Center Community Council. Thanks go to this issue's contributors Julie Bitler, Angela Evans, Tanya Schornack, and Debbie Taback.
Friend on Facebook Follow us on Facebook
(c) 2014 This newsletter is sent on behalf of the Stanford Allergy Center. To opt out of future online communications from the Center, please follow the instructions in the footer of this email.